Evidence map›Paper›PMID 19246474›Full record

Trial reportSocial cognitive and affective neuroscience2009

Noradrenergic enhancement of amygdala responses to fear.

Oezguer A Onur, Henrik Walter, Thomas E Schlaepfer, Anne K Rehme, Christoph Schmidt, Christian Keysers, Wolfgang Maier, René Hurlemann

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Social cognitive and affective neuroscience, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 108 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2010
    Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Stress, associative learning, and decision-making.Neurobiology of learning and memory · 2023
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Neurobiology of fear and specific phobias.Learning & memory (Cold Spring Harbor, N.Y.) · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Oezguer A OnurDepartment of Psychiatry, University of Bonn, 53105 Bonn, Germany.
Henrik Walter
Thomas E Schlaepfer
Anne K Rehme
Christoph Schmidt
Christian Keysers
Wolfgang Maier
René Hurlemann
Imaging Center · USJohns Hopkins University · USUniversity of Bonn · DEUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple lines of evidence implicate the basolateral amygdala (BLA) and the noradrenergic (norepinephrine, NE) system in responding to stressful stimuli such as fear signals, suggesting hyperfunction of both in the development of stress-related pathologies including anxiety disorders. However, no causative link between elevated NE neurotransmission and BLA hyperresponsiveness to fear signals has been established to date in humans. To determine whether or not increased noradrenergic tone enhances BLA responses to fear signals, we used functional magnetic resonance imaging (fMRI) and a strategy of pharmacologically potentiating NE neurotransmission in healthy volunteers. 18 subjects were scanned two times on a facial emotion paradigm and given either a single-dose placebo or 4 mg of the selective NE reuptake inhibitor reboxetine 2 h prior to an fMRI session. We found that reboxetine induced an amygdala response bias towards fear signals that did not exist at placebo baseline. This pharmacological effect was probabilistically mapped to the BLA. Extrapolation of our data to conditions of traumatic stress suggests that disinhibited endogenous NE signaling could serve as a crucial etiological contributor to post-traumatic stress disorder (PTSD) by eliciting exaggerated BLA responses to fear signals.

Indexed as

FearAdrenergic Uptake InhibitorsAdultAmygdalaAnalysis of VarianceBrain MappingDouble-Blind MethodExpressed EmotionFemaleHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleMorpholinesNorepinephrineOxygenAdrenergic Uptake InhibitorsMorpholinesNorepinephrineOxygenReboxetine

Identifiers

PMID19246474
PMCPMC2686227
OpenAlexW2113052000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.